Agile therapeutics and afaxys partner to expand access to twirla® (levonorgestrel and ethinyl estradiol) transdermal system

Princeton, n.j. and charleston, s.c., jan. 10, 2022 (globe newswire) -- agile therapeutics, inc. (nasdaq: agrx), a women's healthcare company, today announced a new alliance with afaxys pharma, llc to promote twirla® (levonorgestrel and ethinyl estradiol) transdermal system.
AGRX Ratings Summary
AGRX Quant Ranking